triptolide has been researched along with Spondylitis, Ankylosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, WZ; Fang, YY; Liu, J; Wan, L; Wen, JT | 1 |
| Cai, J; Li, C; Wang, G; Zhang, J | 1 |
2 other study(ies) available for triptolide and Spondylitis, Ankylosing
| Article | Year |
|---|---|
[Effect of triptolide in improving platelet activation in patients with ankylosing spondylitis by regulating VEGFA,SDF-1,CXCR4 pathway].
Topics: Benzylamines; Cells, Cultured; Chemokine CXCL12; Cyclams; Cytokines; Diterpenes; Epoxy Compounds; Heterocyclic Compounds; Humans; Leukocytes, Mononuclear; Phenanthrenes; Platelet Activation; Receptors, CXCR4; Spondylitis, Ankylosing; Vascular Endothelial Growth Factor A | 2019 |
Mechanism of triptolide in treating ankylosing spondylitis through the anti‑ossification effect of the BMP/Smad signaling pathway.
Topics: Animals; Biomarkers; Bone Morphogenetic Proteins; Cell Proliferation; Cytokines; Disease Models, Animal; Diterpenes; Epoxy Compounds; Female; Fibroblasts; Gene Expression; Immunosuppressive Agents; Male; Osteogenesis; Phenanthrenes; Protein Isoforms; Rats; RNA, Messenger; Signal Transduction; Smad Proteins; Spondylitis, Ankylosing | 2018 |